speb/financial-data huggingface dataset:
CHTR income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 2000000.00
CHTR balance_sheet (quarterly, 2024-09-30) — Treasury Stock: 1103000000.00
CHTR income_statement (annual, 2024-12-31) — +Operating Expense: 17491000000.00
CHTR income_statement (annual, 2024-12-31) — +Total Revenue: 55085000000.00
CHTR balance_sheet (annual, 2024-12-31) — Accounts Payable: 880000000.00
CHTR balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3097000000.00
CHTR balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -39409000000.00
CHTR balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 23337000000.00
CHTR balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -204000000.00
CHTR income_statement (annual, 2024-12-31) — Basic Average Shares: 143061337.00
CHTR income_statement (annual, 2024-12-31) — Basic EPS: 35.53
CHTR cash_flow (annual, 2024-12-31) — Beginning Cash Position: 709000000.00
CHTR balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 5966000000.00
CHTR balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 5966000000.00
CHTR cash_flow (annual, 2024-12-31) — Capital Expenditure: -11269000000.00
CHTR cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: 1096000000.00
CHTR balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
CHTR balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 459000000.00
CHTR balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 459000000.00
CHTR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -3979000000.00
CHTR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -10654000000.00
CHTR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 14430000000.00
CHTR cash_flow (annual, 2024-12-31) — Change In Account Payable: -310000000.00
CHTR cash_flow (annual, 2024-12-31) — Change In Payable: -310000000.00
CHTR cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -310000000.00
CHTR cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -609000000.00
CHTR cash_flow (annual, 2024-12-31) — Change In Receivables: -129000000.00
CHTR cash_flow (annual, 2024-12-31) — Change In Working Capital: -1048000000.00
CHTR cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -129000000.00
CHTR cash_flow (annual, 2024-12-31) — Changes In Cash: -203000000.00
CHTR balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
CHTR balance_sheet (annual, 2024-12-31) — Common Stock Equity: 15587000000.00
CHTR cash_flow (annual, 2024-12-31) — Common Stock Payments: -1213000000.00
CHTR income_statement (annual, 2024-12-31) — Cost Of Revenue: 24349000000.00
CHTR balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 7055000000.00
CHTR balance_sheet (annual, 2024-12-31) — Current Assets: 4233000000.00
CHTR balance_sheet (annual, 2024-12-31) — Current Debt: 2557000000.00
CHTR balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 2557000000.00
CHTR balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 456000000.00
CHTR balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 456000000.00
CHTR balance_sheet (annual, 2024-12-31) — Current Liabilities: 13486000000.00
CHTR cash_flow (annual, 2024-12-31) — Deferred Income Tax: -87000000.00
CHTR cash_flow (annual, 2024-12-31) — Deferred Tax: -87000000.00
CHTR cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 8673000000.00
CHTR income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 8673000000.00
CHTR cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 8673000000.00
CHTR income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 8673000000.00
CHTR income_statement (annual, 2024-12-31) — Diluted Average Shares: 145363771.00
CHTR income_statement (annual, 2024-12-31) — Diluted EPS: 34.97
CHTR income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 5083000000.00
CHTR income_statement (annual, 2024-12-31) — EBIT: 12731000000.00
CHTR income_statement (annual, 2024-12-31) — EBITDA: 21404000000.00
CHTR income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -331000000.00
CHTR cash_flow (annual, 2024-12-31) — End Cash Position: 506000000.00
CHTR cash_flow (annual, 2024-12-31) — Financing Cash Flow: -3979000000.00
CHTR cash_flow (annual, 2024-12-31) — Free Cash Flow: 3161000000.00
CHTR income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 12000000.00
CHTR income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -34000000.00
CHTR income_statement (annual, 2024-12-31) — General And Administrative Expense: 651000000.00
CHTR balance_sheet (annual, 2024-12-31) — Goodwill: 29674000000.00
CHTR balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 98111000000.00
CHTR balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 3301000000.00
CHTR balance_sheet (annual, 2024-12-31) — Gross PPE: 82322000000.00
CHTR income_statement (annual, 2024-12-31) — Gross Profit: 30736000000.00
CHTR cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1581000000.00
CHTR cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 461000000.00
CHTR income_statement (annual, 2024-12-31) — Interest Expense: 5229000000.00
CHTR income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 5229000000.00
CHTR cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 5334000000.00
CHTR balance_sheet (annual, 2024-12-31) — Interest Payable: 1208000000.00
CHTR balance_sheet (annual, 2024-12-31) — Invested Capital: 111350000000.00
CHTR cash_flow (annual, 2024-12-31) — Investing Cash Flow: -10654000000.00
CHTR cash_flow (annual, 2024-12-31) — Issuance Of Debt: 26967000000.00
CHTR balance_sheet (annual, 2024-12-31) — Long Term Debt: 93206000000.00
CHTR balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 93206000000.00
CHTR cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 26967000000.00
CHTR cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -29660000000.00
CHTR balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 9875000000.00
CHTR balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 9875000000.00
CHTR balance_sheet (annual, 2024-12-31) — Minority Interest: 4120000000.00
CHTR income_statement (annual, 2024-12-31) — Minority Interests: -770000000.00
CHTR cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1213000000.00
CHTR balance_sheet (annual, 2024-12-31) — Net Debt: 95304000000.00
CHTR income_statement (annual, 2024-12-31) — Net Income: 5083000000.00
CHTR income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 5083000000.00
CHTR income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 5853000000.00
CHTR income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 5083000000.00
CHTR income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 5083000000.00
CHTR cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 5853000000.00
CHTR income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 5853000000.00
CHTR income_statement (annual, 2024-12-31) — Net Interest Income: -5229000000.00
CHTR cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -2693000000.00
CHTR cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -2693000000.00
CHTR income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -5229000000.00
CHTR cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -105000000.00
CHTR cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 615000000.00
CHTR balance_sheet (annual, 2024-12-31) — Net PPE: 42913000000.00
CHTR cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -11269000000.00
CHTR balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -82524000000.00
CHTR balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 18845000000.00
CHTR balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 18845000000.00
CHTR income_statement (annual, 2024-12-31) — Normalized EBITDA: 21564000000.00
CHTR income_statement (annual, 2024-12-31) — Normalized Income: 5207800000.00
CHTR cash_flow (annual, 2024-12-31) — Operating Cash Flow: 14430000000.00
CHTR income_statement (annual, 2024-12-31) — Operating Income: 13245000000.00
CHTR income_statement (annual, 2024-12-31) — Operating Revenue: 52043000000.00
CHTR balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 141946427.00
CHTR balance_sheet (annual, 2024-12-31) — Other Current Assets: 677000000.00
CHTR balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 2557000000.00
CHTR balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 2557000000.00
CHTR balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1889000000.00
CHTR income_statement (annual, 2024-12-31) — Other Income Expense: -514000000.00
CHTR balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 68437000000.00
CHTR cash_flow (annual, 2024-12-31) — Other Non Cash Items: 388000000.00
CHTR balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 4763000000.00
CHTR balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 4776000000.00
CHTR income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -23000000.00
CHTR income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -27000000.00
CHTR income_statement (annual, 2024-12-31) — Other Operating Expenses: 4577000000.00
CHTR balance_sheet (annual, 2024-12-31) — Other Properties: 66481000000.00
CHTR balance_sheet (quarterly, 2024-12-31) — Other Properties: 66481000000.00
CHTR income_statement (annual, 2024-12-31) — Other Special Charges: 138000000.00
CHTR balance_sheet (annual, 2024-12-31) — Payables: 1529000000.00
CHTR balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 8584000000.00
CHTR balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CHTR income_statement (annual, 2024-12-31) — Pretax Income: 7502000000.00
CHTR cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 32000000.00
CHTR balance_sheet (annual, 2024-12-31) — Properties: 0.00
CHTR balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CHTR cash_flow (annual, 2024-12-31) — Purchase Of PPE: -11269000000.00
CHTR balance_sheet (annual, 2024-12-31) — Receivables: 3097000000.00
CHTR income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 24349000000.00
CHTR income_statement (annual, 2024-12-31) — Reconciled Depreciation: 8673000000.00
CHTR cash_flow (annual, 2024-12-31) — Repayment Of Debt: -29660000000.00
CHTR cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1213000000.00
CHTR income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CHTR balance_sheet (annual, 2024-12-31) — Retained Earnings: -7750000000.00
CHTR income_statement (annual, 2024-12-31) — Salaries And Wages: 651000000.00
CHTR income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 3590000000.00
CHTR income_statement (annual, 2024-12-31) — Selling General And Administration: 4241000000.00
CHTR balance_sheet (annual, 2024-12-31) — Share Issued: 145980996.00
CHTR income_statement (annual, 2024-12-31) — Special Income Charges: -126000000.00
CHTR cash_flow (annual, 2024-12-31) — Stock Based Compensation: 651000000.00
CHTR balance_sheet (annual, 2024-12-31) — Stockholders Equity: 15587000000.00
CHTR balance_sheet (annual, 2024-12-31) — Tangible Book Value: -82524000000.00
CHTR income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -35200000.00
CHTR income_statement (annual, 2024-12-31) — Tax Provision: 1649000000.00
CHTR income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.22
CHTR balance_sheet (annual, 2024-12-31) — Total Assets: 150020000000.00
CHTR balance_sheet (annual, 2024-12-31) — Total Capitalization: 108793000000.00
CHTR balance_sheet (annual, 2024-12-31) — Total Debt: 95763000000.00
CHTR balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 19707000000.00
CHTR income_statement (annual, 2024-12-31) — Total Expenses: 41840000000.00
CHTR balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 130313000000.00
CHTR balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 145787000000.00
CHTR balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 116827000000.00
CHTR income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 13118000000.00
CHTR balance_sheet (annual, 2024-12-31) — Total Tax Payable: 649000000.00
CHTR income_statement (annual, 2024-12-31) — Total Unusual Items: -160000000.00
CHTR income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -160000000.00
CHTR balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 4034569.00
CHTR balance_sheet (annual, 2024-12-31) — Working Capital: -9253000000.00
CHTR income_statement (quarterly, 2025-03-31) — +Operating Expense: 4435000000.00
CHTR income_statement (quarterly, 2025-03-31) — +Total Revenue: 13735000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 929000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3311000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -40033000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 23586000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -214000000.00
CHTR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 141591396.00
CHTR income_statement (quarterly, 2025-03-31) — Basic EPS: 8.59
CHTR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 506000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -2672000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -273000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
CHTR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 796000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 796000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1072000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -2804000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 4236000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 493000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Change In Payable: 493000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 493000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -235000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Change In Receivables: -48000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 210000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -48000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Changes In Cash: 360000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
CHTR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 16247000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -802000000.00
CHTR income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5940000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 6787000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Current Assets: 4968000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Current Debt: 2393000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2393000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 477000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 477000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 13672000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -27000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Deferred Tax: -27000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2181000000.00
CHTR income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 2181000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2181000000.00
CHTR income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2181000000.00
CHTR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 144574684.00
CHTR income_statement (quarterly, 2025-03-31) — Diluted EPS: 8.42
CHTR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1217000000.00
CHTR income_statement (quarterly, 2025-03-31) — EBIT: 3095000000.00
CHTR income_statement (quarterly, 2025-03-31) — EBITDA: 5276000000.00
CHTR income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -77000000.00
CHTR cash_flow (quarterly, 2025-03-31) — End Cash Position: 866000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1072000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1564000000.00
CHTR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -91000000.00
CHTR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -65000000.00
CHTR income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 222000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Goodwill: 29674000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 97960000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3525000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Gross PPE: 83392000000.00
CHTR income_statement (quarterly, 2025-03-31) — Gross Profit: 7795000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 56000000.00
CHTR income_statement (quarterly, 2025-03-31) — Interest Expense: 1241000000.00
CHTR income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1241000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 995000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Interest Payable: 1452000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 111804000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -2804000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1514000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 93164000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 93164000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1514000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1609000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Minority Interest: 4275000000.00
CHTR income_statement (quarterly, 2025-03-31) — Minority Interests: -192000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -802000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Net Debt: 94761000000.00
CHTR income_statement (quarterly, 2025-03-31) — Net Income: 1217000000.00
CHTR income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1217000000.00
CHTR income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1409000000.00
CHTR income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1217000000.00
CHTR income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1217000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1409000000.00
CHTR income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1409000000.00
CHTR income_statement (quarterly, 2025-03-31) — Net Interest Income: -1241000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -95000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -95000000.00
CHTR income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1241000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -192000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -132000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Net PPE: 43359000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2399000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -81713000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 18822000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 18822000000.00
CHTR income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 5464000000.00
CHTR income_statement (quarterly, 2025-03-31) — Normalized Income: 1359875943.91
CHTR cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 4236000000.00
CHTR income_statement (quarterly, 2025-03-31) — Operating Income: 3360000000.00
CHTR income_statement (quarterly, 2025-03-31) — Operating Revenue: 12942000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 140364227.00
CHTR balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 861000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 2062000000.00
CHTR income_statement (quarterly, 2025-03-31) — Other Income Expense: -265000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 68286000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 241000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 4667000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 4774000000.00
CHTR income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1083000000.00
CHTR income_statement (quarterly, 2025-03-31) — Other Special Charges: 32000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Payables: 1953000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 8740000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CHTR income_statement (quarterly, 2025-03-31) — Pretax Income: 1854000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 17000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2399000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Receivables: 3311000000.00
CHTR income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5940000000.00
CHTR income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2181000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1609000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -802000000.00
CHTR income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
CHTR balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -6533000000.00
CHTR income_statement (quarterly, 2025-03-31) — Salaries And Wages: 222000000.00
CHTR income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 949000000.00
CHTR income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1171000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Share Issued: 142640862.00
CHTR income_statement (quarterly, 2025-03-31) — Special Income Charges: -123000000.00
CHTR cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 222000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 16247000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -81713000000.00
CHTR income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -45124056.09
CHTR income_statement (quarterly, 2025-03-31) — Tax Provision: 445000000.00
CHTR income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
CHTR balance_sheet (quarterly, 2025-03-31) — Total Assets: 150954000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 109411000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Total Debt: 95557000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 20522000000.00
CHTR income_statement (quarterly, 2025-03-31) — Total Expenses: 10375000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 130432000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 145986000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 116760000000.00
CHTR income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 3237000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 1024000000.00
CHTR income_statement (quarterly, 2025-03-31) — Total Unusual Items: -188000000.00
CHTR income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -188000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 2276635.00
CHTR balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 806000000.00
CHTR balance_sheet (quarterly, 2025-03-31) — Working Capital: -8704000000.00
CHTR income_statement (quarterly, 2025-06-30) — +Operating Expense: 4417000000.00
CHTR income_statement (quarterly, 2025-06-30) — +Total Revenue: 13766000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 967000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 3549000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -40733000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 23714000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -233000000.00
CHTR income_statement (quarterly, 2025-06-30) — Basic Average Shares: 138205810.00
CHTR income_statement (quarterly, 2025-06-30) — Basic EPS: 9.41
CHTR cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 866000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2601000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
CHTR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 606000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 606000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1196000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2621000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 3600000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -127000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Change In Payable: -127000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -127000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 66000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Change In Receivables: -238000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -299000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -238000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Changes In Cash: -217000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
CHTR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 16209000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -1451000000.00
CHTR income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 5989000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 7085000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Current Assets: 4812000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Current Debt: 3114000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3114000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 457000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 457000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 14556000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -53000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Deferred Tax: -53000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2176000000.00
CHTR income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 2176000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2176000000.00
CHTR income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 2176000000.00
CHTR income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 141684415.00
CHTR income_statement (quarterly, 2025-06-30) — Diluted EPS: 9.18
CHTR income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1301000000.00
CHTR income_statement (quarterly, 2025-06-30) — EBIT: 3172000000.00
CHTR income_statement (quarterly, 2025-06-30) — EBITDA: 5348000000.00
CHTR income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -127000000.00
CHTR cash_flow (quarterly, 2025-06-30) — End Cash Position: 649000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1196000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 999000000.00
CHTR income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: -9000000.00
CHTR income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 20000000.00
CHTR income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 157000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Goodwill: 29674000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 97814000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 3782000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Gross PPE: 84920000000.00
CHTR income_statement (quarterly, 2025-06-30) — Gross Profit: 7777000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 657000000.00
CHTR income_statement (quarterly, 2025-06-30) — Interest Expense: 1263000000.00
CHTR income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1263000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 1444000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Interest Payable: 1271000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 112492000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2621000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 3835000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 93169000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 93169000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 3835000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -3184000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Minority Interest: 4159000000.00
CHTR income_statement (quarterly, 2025-06-30) — Minority Interests: -194000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -1451000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Net Debt: 95677000000.00
CHTR income_statement (quarterly, 2025-06-30) — Net Income: 1301000000.00
CHTR income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1301000000.00
CHTR income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1495000000.00
CHTR income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1301000000.00
CHTR income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1301000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1495000000.00
CHTR income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1495000000.00
CHTR income_statement (quarterly, 2025-06-30) — Net Interest Income: -1263000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 651000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 651000000.00
CHTR income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1263000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -398000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -20000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Net PPE: 44187000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2874000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -81605000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 18757000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 18757000000.00
CHTR income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 5409000000.00
CHTR income_statement (quarterly, 2025-06-30) — Normalized Income: 1348771084.34
CHTR cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 3600000000.00
CHTR income_statement (quarterly, 2025-06-30) — Operating Income: 3360000000.00
CHTR income_statement (quarterly, 2025-06-30) — Operating Revenue: 12927000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 136590985.00
CHTR balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 657000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 2089000000.00
CHTR income_statement (quarterly, 2025-06-30) — Other Income Expense: -188000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 68140000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 124000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 4776000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 4739000000.00
CHTR income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1126000000.00
CHTR income_statement (quarterly, 2025-06-30) — Other Special Charges: 29000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Payables: 1811000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 8896000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CHTR income_statement (quarterly, 2025-06-30) — Pretax Income: 1909000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 2000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2874000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Receivables: 3549000000.00
CHTR income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 5989000000.00
CHTR income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2176000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -3184000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -1451000000.00
CHTR income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 43000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -5232000000.00
CHTR income_statement (quarterly, 2025-06-30) — Salaries And Wages: 157000000.00
CHTR income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 958000000.00
CHTR income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1115000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Share Issued: 142812047.00
CHTR income_statement (quarterly, 2025-06-30) — Special Income Charges: -81000000.00
CHTR cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 157000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 16209000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -81605000000.00
CHTR income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -13228915.66
CHTR income_statement (quarterly, 2025-06-30) — Tax Provision: 414000000.00
CHTR income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.22
CHTR balance_sheet (quarterly, 2025-06-30) — Total Assets: 151589000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 109378000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Total Debt: 96283000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 20368000000.00
CHTR income_statement (quarterly, 2025-06-30) — Total Expenses: 10406000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 131221000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 146777000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 116665000000.00
CHTR income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 3279000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 844000000.00
CHTR income_statement (quarterly, 2025-06-30) — Total Unusual Items: -61000000.00
CHTR income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -61000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 6221062.00
CHTR balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 2273000000.00
CHTR balance_sheet (quarterly, 2025-06-30) — Working Capital: -9744000000.00
CHTR income_statement (quarterly, 2025-09-30) — +Operating Expense: 4419000000.00
CHTR income_statement (quarterly, 2025-09-30) — +Total Revenue: 13672000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 965000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3598000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -41239000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 23842000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -234000000.00
CHTR income_statement (quarterly, 2025-09-30) — Basic Average Shares: 133763886.00
CHTR income_statement (quarterly, 2025-09-30) — Basic EPS: 8.50
CHTR cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 649000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3051000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
CHTR balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 464000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 464000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1451000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3157000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 4480000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 80000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Change In Payable: 80000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 80000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -186000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Change In Receivables: -48000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -154000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -48000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Changes In Cash: -128000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
CHTR balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 15340000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -2113000000.00
CHTR income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 6003000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 7569000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Current Assets: 4867000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Current Debt: 1287000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1287000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 441000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 441000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 12994000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 852000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Deferred Tax: 852000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2160000000.00
CHTR income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 2160000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2160000000.00
CHTR income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 2160000000.00
CHTR income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 136395133.00
CHTR income_statement (quarterly, 2025-09-30) — Diluted EPS: 8.34
CHTR income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1137000000.00
CHTR income_statement (quarterly, 2025-09-30) — EBIT: 3002000000.00
CHTR income_statement (quarterly, 2025-09-30) — EBITDA: 5162000000.00
CHTR income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -78000000.00
CHTR cash_flow (quarterly, 2025-09-30) — End Cash Position: 521000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1451000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 1429000000.00
CHTR income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -19000000.00
CHTR income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -35000000.00
CHTR income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 151000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Goodwill: 29710000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 97733000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 3832000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Gross PPE: 86426000000.00
CHTR income_statement (quarterly, 2025-09-30) — Gross Profit: 7669000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 54000000.00
CHTR income_statement (quarterly, 2025-09-30) — Interest Expense: 1268000000.00
CHTR income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1268000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 1171000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Interest Payable: 1367000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Invested Capital: 112405000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3157000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 6962000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 95778000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 95778000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 6962000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -6128000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Minority Interest: 4248000000.00
CHTR income_statement (quarterly, 2025-09-30) — Minority Interests: -179000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -2113000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Net Debt: 96601000000.00
CHTR income_statement (quarterly, 2025-09-30) — Net Income: 1137000000.00
CHTR income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1137000000.00
CHTR income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1316000000.00
CHTR income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1137000000.00
CHTR income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1137000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 1316000000.00
CHTR income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1316000000.00
CHTR income_statement (quarterly, 2025-09-30) — Net Interest Income: -1268000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 834000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 834000000.00
CHTR income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1268000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -173000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -106000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Net PPE: 45187000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -3051000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -82393000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 19604000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 19604000000.00
CHTR income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 5344000000.00
CHTR income_statement (quarterly, 2025-09-30) — Normalized Income: 1275126874.28
CHTR cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 4480000000.00
CHTR income_statement (quarterly, 2025-09-30) — Operating Income: 3250000000.00
CHTR income_statement (quarterly, 2025-09-30) — Operating Revenue: 12836000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 129409367.00
CHTR balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 805000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2224000000.00
CHTR income_statement (quarterly, 2025-09-30) — Other Income Expense: -248000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 68023000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 155000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 5063000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 4886000000.00
CHTR income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 12000000.00
CHTR income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1132000000.00
CHTR income_statement (quarterly, 2025-09-30) — Other Special Charges: 107000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Payables: 1473000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 9042000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CHTR income_statement (quarterly, 2025-09-30) — Pretax Income: 1734000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 1000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -3051000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Receivables: 3598000000.00
CHTR income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 6003000000.00
CHTR income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2160000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -6128000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -2113000000.00
CHTR income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 21000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -4095000000.00
CHTR income_statement (quarterly, 2025-09-30) — Salaries And Wages: 151000000.00
CHTR income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 976000000.00
CHTR income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1127000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Share Issued: 142990101.00
CHTR income_statement (quarterly, 2025-09-30) — Special Income Charges: -147000000.00
CHTR cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 151000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 15340000000.00
CHTR balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -82393000000.00